Trevi Therapeutics (TRVI) Other Working Capital Changes (2020 - 2026)

Trevi Therapeutics' Other Working Capital Changes history runs 7 years deep, the most recent figure standing at $2.8 million for Q1 2026.

• In Q1 2026, Other Working Capital Changes rose 369.09% year-over-year to $2.8 million; the TTM figure through Mar 2026 stood at $3.7 million (up 352.45% YoY), while the FY2025 annual figure was $1.5 million, up 155.58% from the prior year.
• Other Working Capital Changes for Q1 2026 stood at $2.8 million, up from -$158000.0 in the prior quarter.
• The five-year high for Other Working Capital Changes was $2.8 million in Q1 2026, with the low at -$1.3 million in Q2 2024.
• The 5-year median for Other Working Capital Changes is $30000.0 (2025), against an average of $300470.6.
• The sharpest annual moves came in 2023 and 2026: Other Working Capital Changes tumbled 486.36% in 2023, then soared 369.09% in 2026.
• Trevi Therapeutics' Other Working Capital Changes stood at $22000.0 in 2022, then sank by 486.36% to -$85000.0 in 2023, then soared by 190.59% to $77000.0 in 2024, then sank by 305.19% to -$158000.0 in 2025, then surged by 1896.2% to $2.8 million in 2026.
• Business Quant data shows TRVI's Other Working Capital Changes at $2.8 million in Q1 2026, -$158000.0 in Q4 2025, and $30000.0 in Q3 2025.